SynthesisAlzheimer's & dementia : the journal of the Alzheimer's Association2024

CT1812 biomarker signature from a meta-analysis of CSF proteomic findings from two Phase 2 clinical trials in Alzheimer's disease.

Britney N Lizama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.